India's MedPlus down after suspension of unit's drug license
** Shares of MedPlus Health Services MEDP.NS fall 2.2% to
729.7 rupees
** Drug retailer said on Thursday its unit received an order
for the suspension of its drug license for five days
** Stock among top losers on Nifty Smallcap 100
index .NIFSMCP100
** MEDP on track for second consecutive quarterly fall, if
trend holds; stock down over 5% during the period
** Stock currently trading 25% below its median PT of 974
rupees - LSEG data
** Stock trims gains, up 20% YTD
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on MedPlus Health Services
See all newsBrief: Medplus Health Services Keeps Food Park And Concierge Health Facility Capex In Abeyance
India's Medplus Health Services set for worst day on record as Q1 profit plunges
India's MedPlus Health first quarter profit drops as expansion costs and competition weigh
Brief: Medplus Health Services Says Optival Health Solutions Receives Suspension Order For Drug License Of Store In Karnataka
Brief: Medplus Health Services Says Unit Optival Health Solutions Receives Three Drug License Suspension Orders In Karnataka And Andhra Pradesh